- Entry level
- No Education
- Salary to negotiate
- Petaling Jaya
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines for some of the world's most serious diseases. But we're more than one of the world's leading pharmaceutical companies. At AstraZeneca, we're proud to have a unique workplace culture that inspires innovation and collaboration. Here, employees are empowered to express diverse perspectives - and are made to feel valued, energised and rewarded for their ideas and creativity.
Global Finance Services is at the heart of the Finance function - accountable to the AstraZeneca (AZ) Group for the design and delivery of high quality, simple to operate transactional finance processes that enable our customers to focus on AZ’s strategic priorities.
Our processes cover record to report, purchase to pay and order to cash and we drive AZ’s cash focus through disciplined management of supplier and customer payment terms and practices. GFO provides P2P/T&E process helpdesk services to internal AZ and external end users, including training support to internal AZ users. Plans are in place to extend the scope and internal customer coverage during 2017.
Global Finance Services operates globally through a combination of in-house captive and offshored business process outsourcing (BPO). The BPO element has been provided in partnership with our service provider partner Genpact since 2008.
The purchase to pay (P2P)) team within Global Finance Services is responsible for processing invoices and making payments to our suppliers, reimbursing expenses to employees, managing vendor & contract data, processing purchase orders and ensuring process and policy compliance. We operate across all our employees and everyone can buy and travel if the role requires (59,700 employees). We pay over 1 million invoices a year with a value of over $1bn a month and pay over 760,000 travel and expense claims for employees with a value of $640M a year. Partnering with our helpdesk we handle approx. 40000 helpdesks queries a year.
Deliver a professional and consistent service to customers. Support in resolving Local Country inquiries for the PTP function.
Perform the various tasks related to, and established for, handling invoice and T&E transaction processing within well defined guidelines, including resolving basic queries and investigations in a timely manner in the area of PTP.
Carry out AP closing activities accurately including preparing and analyse BS reconciliation reports within specified timescales. Prepares and produces monthly reports as assigned; identifies long outstanding items reflected in the accounts.
Support the development/changes in systems, transactions and processes. This includes preparing and updating process documentation.
Work collaboratively with internal customers and stakeholders.
Support Team Lead and team members in activities to enhance the effectiveness of the team. This includes helping new joiners to successfully settle into their new role in their stream.
Ensure compliance to key controls as identified in the FCF/SOX documentation.
Generate and compile KPI metrics related to PtP and T&E function at month end.
Support Senior Analyst or Team Lead when there are any ad hoc activities or project.
Candidates must have at least Diploma in Finance & Accounting/Commerce or equivalent
Possess 1-2 years of accounting work experiences
Fresh graduates and candidates pursuing a professional qualification (Part Time) in ACCA, CIMA or any other relevant qualification are encouraged to apply
Knowledge and experience in SAP, Oracle or other ERP system will be an added advantage
Experience of working in a shared service centre across a global /large organization will be an added advantage
Good communication skill and able to communicate effectively in English and Mandarin.
Where required, proficiency in a particular foreign language is needed.
About the company
AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines.
We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines.
We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies.
Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.